Found 0 matching trials
Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities PHASE2 Positron Emission Tomography (PET scanning) is performed using a total dose...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT PHASE1 68Ga-fibroblast activating protein inhibitors(FAPI) has been developed as a...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
18F-FDG PET/CT for IgG4-Related Disease EARLY_PHASE1 This is an open-label study to investigate the diagnostic performance of 18...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Learn More & Join Trial
Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis PHASE2 The purpose of the study is to assess the effect of BMS-823778 on reducing ...
Show More Location
Multiple Locations
Learn More & Join Trial
FDG-PET Imaging in Complicated Diabetic Foot N/A The main objective of the proposed research study is to determine the poten...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
PET Imaging of Endotoxin-induced iNOS Activation PHASE1 The overall purpose of this research is to gain understanding of the basic ...
Show More Location
Washington University School of Medicne
Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors. N/A Neuroendocrine tumors (NETs) constitute approximately 0.5% of malignancies....
Show More Location
Irccs San Raffaele
Learn More & Join Trial
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery PHASE1 This pilot clinical trial studies gene expression analysis and fludeoxygluc...
Show More Location
Washington University School of Medicine
Learn More & Join Trial